Impel NeuroPharma Archives

Press ESC key to close search

Oaktree Capital Management Provides $100MM in Financing to Impel Neuropharma

Oaktree Capital Management closed two separate transactions totaling $100 million in gross funding for Impel NeuroPharma, a commercial-stage pharmaceutical company. The transactions include $50 million of senior secured debt.

Oxford Finance and SVB Provide $50MM Debt Facility to Impel NeuroPharma

Impel NeuroPharma, a late-stage biopharmaceutical company, closed a $50 million debt facility with Oxford Finance and Silicon Valley Bank. The first $20 million of the facility was funded at closing.

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: Impel NeuroPharma

Oaktree Capital Management Provides $100MM in Financing to Impel Neuropharma

Oxford Finance and SVB Provide $50MM Debt Facility to Impel NeuroPharma